Zhengye Biotechnology Holding (ZYBT) Equity Ratio (2023 - 2025)
Historic Equity Ratio for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Q2 2025 value amounting to 0.72.
- Zhengye Biotechnology Holding's Equity Ratio changed N/A to 0.72 in Q2 2025 from the same period last year, while for Jun 2025 it was 0.72, marking a year-over-year change of. This contributed to the annual value of 0.71 for FY2024, which is 530.98% up from last year.
- Latest data reveals that Zhengye Biotechnology Holding reported Equity Ratio of 0.72 as of Q2 2025.
- Zhengye Biotechnology Holding's Equity Ratio's 5-year high stood at 0.72 during Q2 2025, with a 5-year trough of 0.68 in Q4 2023.
- In the last 3 years, Zhengye Biotechnology Holding's Equity Ratio had a median value of 0.71 in 2024 and averaged 0.71.
- Within the past 5 years, the most significant YoY rise in Zhengye Biotechnology Holding's Equity Ratio was 530.98% (2024), while the steepest drop was 530.98% (2024).
- Over the past 3 years, Zhengye Biotechnology Holding's Equity Ratio (Quarter) stood at 0.68 in 2023, then grew by 5.31% to 0.71 in 2024, then grew by 1.23% to 0.72 in 2025.
- Its Equity Ratio was 0.72 in Q2 2025, compared to 0.71 in Q4 2024 and 0.68 in Q4 2023.